IMDX Long Call Strategy

IMDX (Insight Molecular Diagnostics Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.

OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early-stage adenocarcinoma of the lung; and DetermaIO, a proprietary gene expression assay. It also provides biomarker discovery testing, assay design and development, and clinical trial support services, as well as various biomarker tests for pharmaceutical companies. The company has a collaboration agreement with Life Technologies Corporation to develop and collaborate in the commercialization of Oncomine Comprehensive Assay Plus and Determa IO assay for use with Ion Torrent Genexus integrated sequencer and purification system. OncoCyte Corporation was incorporated in 2009 and is based in Irvine, California.

IMDX (Insight Molecular Diagnostics Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $136.9M, a beta of 1.63 versus the broader market, a 52-week range of 2.33-8.51, average daily share volume of 295K, a public-listing history dating back to 2015, approximately 46 full-time employees. These structural characteristics shape how IMDX stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of 1.63 indicates IMDX has historically moved more than the broader market, amplifying both the directional payoff and the realized volatility relative to an index-equivalent position.

What is a long call on IMDX?

A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration.

Current IMDX snapshot

As of May 15, 2026, spot at $6.37, ATM IV 134.50%, expected move 38.56%. The long call on IMDX below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.

Why this long call structure on IMDX specifically: IV rank is unavailable in the current snapshot, so regime-based timing for IMDX is inferred from ATM IV at 134.50% alone, with a market-implied 1-standard-deviation move of approximately 38.56% (roughly $2.46 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated IMDX expiries trade a higher absolute premium for lower per-day decay. Position sizing on IMDX should anchor to the underlying notional of $6.37 per share and to the trader's directional view on IMDX stock.

IMDX long call setup

The IMDX long call below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With IMDX near $6.37, the first option leg uses a $6.37 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed IMDX chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 IMDX shares for the stock leg in covered calls and collars).

ActionTypeStrike / BasisPremium (est)
Buy 1Call$6.37N/A

IMDX long call risk and reward

Net Premium / Debit
N/A
Max Profit (per contract)
Unbounded
Max Loss (per contract)
Unbounded
Breakeven(s)
None on modeled curve
Risk / Reward Ratio
N/A

Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium.

IMDX long call payoff curve

Modeled P&L at expiration across a range of underlying prices for the long call on IMDX. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

When traders use long call on IMDX

Long calls on IMDX express a bullish thesis with defined risk; traders use them ahead of IMDX catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.

IMDX thesis for this long call

The market-implied 1-standard-deviation range for IMDX extends from approximately $3.91 on the downside to $8.83 on the upside. A IMDX long call expresses a directional view that the underlying closes above the strike plus premium at expiration, ideally with implied volatility holding or expanding to preserve extrinsic value through the hold period. As a Healthcare name, IMDX options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to IMDX-specific events.

IMDX long call positions are structurally bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. IMDX positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move IMDX alongside the broader basket even when IMDX-specific fundamentals are unchanged. Long-premium structures like a long call on IMDX are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current IMDX chain quotes before placing a trade.

Frequently asked questions

What is a long call on IMDX?
A long call on IMDX is the long call strategy applied to IMDX (stock). The strategy is structurally bullish: A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration. With IMDX stock trading near $6.37, the strikes shown on this page are snapped to the nearest listed IMDX chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
How are IMDX long call max profit and max loss calculated?
Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium. For the IMDX long call priced from the end-of-day chain at a 30-day expiry (ATM IV 134.50%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a IMDX long call?
The breakeven for the IMDX long call priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current IMDX market-implied 1-standard-deviation expected move is approximately 38.56%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a long call on IMDX?
Long calls on IMDX express a bullish thesis with defined risk; traders use them ahead of IMDX catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.
How does current IMDX implied volatility affect this long call?
Current IMDX ATM IV is 134.50%; IV rank context is unavailable in the current snapshot.

Related IMDX analysis